Back
Verrica Pharmaceuticals Stock Price Chart
Sponsored
VRCA
Sponsored
Could This Stock Under $5 Be Your Biggest Opportunity?
Click here to learn more.
Sell
37
VRCA
Verrica Pharmaceuticals
Last Price:
$0.73
Seasonality Move:
20.88%
7 Day Trial
ALL ACCESS PASS
$
7
Elon Musk Dreams, Mode Mobile Delivers
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRCA is experiencing buying pressure, which is a positive indicator for future bullish movement.
Verrica Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.69 | Buy |
20-day SMA: | 0.73 | Buy |
50-day SMA: | 0.96 | Sell |
200-day SMA: | 4.38 | Sell |
8-day EMA: | 0.71 | Buy |
20-day EMA: | 0.76 | Sell |
50-day EMA: | 1.06 | Sell |
200-day EMA: | 3.19 | Sell |
Verrica Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.09 | Sell |
Relative Strength Index (14 RSI): | 43.83 | Sell |
Chaikin Money Flow: | 489674 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.63 - 0.99) | Sell |
Bollinger Bands (100): | (0.79 - 2.09) | Sell |
Verrica Pharmaceuticals Technical Analysis
Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Verrica Pharmaceuticals Stock
Is Verrica Pharmaceuticals Stock a Buy?
-
Verrica Pharmaceuticals share price is 0.75 while VRCA 8-day simple moving average is 0.69, which is a Buy signal.
-
The stock price of VRCA is 0.75 while Verrica Pharmaceuticals 20-day SMA is 0.73, which makes it a Buy.
-
Verrica Pharmaceuticals 50-day simple moving average is 0.96 while VRCA share price is 0.75, making it a Sell technically.
-
VRCA stock price is 0.75 and Verrica Pharmaceuticals 200-day simple moving average is 4.38, creating a Sell signal.
VRCA Technical Analysis vs Fundamental Analysis
Sell
37
Verrica Pharmaceuticals (VRCA)
is a Sell
Is Verrica Pharmaceuticals a Buy or a Sell?
-
Verrica Pharmaceuticals stock is rated a SellThe current Verrica Pharmaceuticals [VRCA] share price is $0.75. The Score for VRCA is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Verrica Pharmaceuticals Stock Info
Market Cap:
67.9M
Price in USD:
0.75
Share Volume:
565K
Verrica Pharmaceuticals 52-Week Range
52-Week High:
11.41
52-Week Low:
0.61
Sell
37
Verrica Pharmaceuticals (VRCA)
is a Sell
Verrica Pharmaceuticals Share Price Forecast
-
What is the Verrica Pharmaceuticals stock price today?The Verrica Pharmaceuticals stock price is 0.75 USD today.
-
Will VRCA stock go up or go down?Verrica Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Verrica Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Verrica Pharmaceuticals is overvalued.
Is Verrica Pharmaceuticals Stock a Buy?
-
Verrica Pharmaceuticals share price is 0.75 while VRCA 8-day exponential moving average is 0.71, which is a Buy signal.
-
The stock price of VRCA is 0.75 while Verrica Pharmaceuticals 20-day EMA is 0.76, which makes it a Sell.
-
Verrica Pharmaceuticals 50-day exponential moving average is 1.06 while VRCA share price is 0.75, making it a Sell technically.
-
VRCA stock price is 0.75 and Verrica Pharmaceuticals 200-day simple moving average is 3.19, creating a Sell signal.
Fundamental Analysis of Verrica Pharmaceuticals
Is Verrica Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.83 per share, and an increase next year of $0.20 per share.
Technical Analysis of Verrica Pharmaceuticals
Should I short Verrica Pharmaceuticals stock?
-
VRCA Moving Average Covergence Divergence (MACD) indicator is -0.09, suggesting Verrica Pharmaceuticals is a Sell
-
Verrica Pharmaceuticals Relative Strength Index (RSI) is 43.83, which suggest Verrica Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Verrica Pharmaceuticals is (0.63 - 0.99), which suggest Verrica Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Verrica Pharmaceuticals is (0.79 - 2.09), which suggest Verrica Pharmaceuticals is a Sell
* Verrica Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.